Reblozyl 75 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FM1ZT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,658
Award facts
- Contract value 100% obligated
- $34,658.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,658.44 delivery order to AmerisourceBergen Drug Corp on January 8, 2026, for the supply of Reblozyl 75 mg vials, with an ultimate completion date of January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally, covering specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet diverse pharmaceutical supply requirements through open competition. This delivery order for Reblozyl—a specialty pharmaceutical product used in medical treatment protocols—reflects the company's continued role in supporting the Defense Logistics Agency's Medical Supply Chain and federal healthcare missions across military treatment facilities and related government medical institutions.
Quick answers
Who was awarded contract SPE2DR26FM1ZT?
SPE2DR26FM1ZT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FM1ZT worth?
The government has obligated $34,658 on SPE2DR26FM1ZT.
Is contract SPE2DR26FM1ZT an order under another contract?
Yes. SPE2DR26FM1ZT is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM1ZT competed?
The extent of competition for SPE2DR26FM1ZT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award